Algin and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Algin (algin) and Vancomycin (vancomycin). Common drug interactions include cytokine release syndrome among females and amnesia among males.

The phase IV clinical study analyzes what interactions people have when they take Algin and Vancomycin. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Algin?

Algin has active ingredients of algin. eHealthMe is studying from 1,584 Algin users. Check the latest studies of Algin.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On Jul, 12, 2026

25 people who take Algin and Vancomycin together, and have interactions are studied.

Algin and Vancomycin drug interactions.

What are the common drug interactions of Algin and Vancomycin, by gender? *:

female:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Hepatosplenic candidiasis (fungal infection in liver and spleen)
  3. Lung neoplasm malignant (cancer tumour of lung)
  4. Oxygen saturation decreased
  5. Renal colic (renal pain)

male:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Confusional state
  3. Haematochezia (passage of stools containing blood)
  4. Intervertebral discitis (infection in the intervertebral disc space)
  5. Melaena (the passage of black, tarry stools)
  6. Post procedural haemorrhage (post procedural bleeding)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Abscess limb (limb infection)
  9. Anal abscess
  10. Cellulitis of male external genital organ (infection of male genitals soft tissue)

What are the common drug interactions of Algin and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Rhinovirus infection

20-29:

  1. Oesophagitis (inflammation of oesophagus)
  2. Haematochezia (passage of stools containing blood)
  3. Melaena (the passage of black, tarry stools)
  4. Thrombocytopenia (decrease of platelets in blood)

30-39:

n/a

40-49:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Confusional state
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Cellulitis (infection under the skin)

50-59:

  1. Abscess limb (limb infection)
  2. Anal abscess
  3. Cellulitis (infection under the skin)
  4. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  5. Erythema (redness of the skin)
  6. Genital abscess (build up of pus in genital)
  7. Groin abscess (pus in groin)
  8. Perirectal abscess
  9. Pyrexia (fever)
  10. Scrotal abscess (pus in scrotum)

60+:

  1. Blood uric acid increased
  2. Cardiac disorder
  3. Cardiac failure
  4. Gastric cancer (stomach cancer)
  5. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  6. Hepatosplenic candidiasis (fungal infection in liver and spleen)
  7. Intervertebral discitis (infection in the intervertebral disc space)
  8. Post procedural haemorrhage (post procedural bleeding)

What are the existing conditions these people have? *

  1. Pain: 13 people, 52.00%
  2. Fever: 13 people, 52.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 48.00%
  4. Diarrhea: 11 people, 44.00%
  5. High Blood Pressure: 10 people, 40.00%
  6. Fungal Infection: 10 people, 40.00%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 10 people, 40.00%
  8. Cellulitis (infection under the skin): 10 people, 40.00%
  9. Abdominal Pain: 10 people, 40.00%
  10. Insomnia (sleeplessness): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Algin and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Algin and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Algin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Algin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on algin and vancomycin (the active ingredients of Algin and Vancomycin, respectively), and Algin and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: